Page last updated: 2024-10-24

celecoxib and Cataract

celecoxib has been researched along with Cataract in 1 studies

Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Both rofecoxib and celecoxib were effective at inhibiting PCO formation in our ex vivo model."1.34Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition. ( Barden, CA; Chandler, HL; Colitz, CM; Kusewitt, DF; Lu, P, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chandler, HL1
Barden, CA1
Lu, P1
Kusewitt, DF1
Colitz, CM1

Other Studies

1 other study available for celecoxib and Cataract

ArticleYear
Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.
    Molecular vision, 2007, Apr-30, Volume: 13

    Topics: Animals; Apoptosis; Biomarkers; Cataract; Celecoxib; Cell Differentiation; Cell Movement; Cell Proli

2007